GTC Biotherapeutics (fka GTCB)

[vinmantoo]

When two drugs are designed to treat the same problem, but they function in different pathways, there is the potential for synergy in combination therapy. The paradigm is how HIV is treated. It is far to early to say if that will be the case with ATIII and ART123. I need to read a bit about their mechanisms of action but don't have the time right now. Perhaps in a month I will.

Vinny


P.S. I put in a limit order for GTCB this afternoon at $1 but it din't get filled even thought GTCB reached $1 twice afterward and closed at $1. I guess I am too much of a small fry. I think we are getting close to the time when the summer biotech swoon ends.